Evalve posts

Feed

Earnings preview: Abbott Labs Q3 acquisitions to pay off?

Abbott Laboratories (NYSE: ABT), the broad-based health care company that produces both Humira and Similac, is scheduled to discuss its third quarter 2009 financial results in a conference call Wednesday at 9:00 AM ET. You can catch the live webcast on the company's website.

During the three months that ended in September, Abbott Labs announced acquisitions of Visiogen, Evalve, and Solvay pharmaceuticals, as well as declared its 343rd consecutive quarterly dividend. Analysts surveyed by Thomson Reuters expect this suburban Chicago company to report that earnings rose 12.2% from a year ago to $0.90 per share. Sales for the quarter are expected to be 3.3% higher to $7.8 billion.

Continue reading Earnings preview: Abbott Labs Q3 acquisitions to pay off?

Symbol Lookup
IndexesChangePrice
DJIA+68.1112,869.34
NASDAQ+24.802,928.68
S&P 500+8.371,351.01

Last updated: February 13, 2012: 04:11 PM

Hot Stocks

General Electric

19.045+0.17(+0.90)

Alcoa

10.315+0.025(+0.24)

Apple Inc

502.45+9.03(+1.83)

Google Inc 'A'

611.86+5.95(+0.98)

Bank of America

8.255+0.185(+2.29)

Wal-Mart Stores

61.765-0.135(-0.22)

Exxon Mobil Corp

84.395+0.595(+0.71)

Ford

12.535+0.095(+0.76)

Citigroup

32.89-0.035(-0.11)

IBM

192.49+0.07(+0.04)

Yahoo

16.105-0.035(-0.22)

Starbucks

49.235+0.415(+0.85)

Microsoft

30.555+0.06(+0.20)

Home Depot

45.935+0.605(+1.33)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1329167495446 ms.